The Mesothelioma Applied Research Foundation’s 2020 mesothelioma research grant cycle is now accepting pre-application letters of intent (LOI) until 11:59 PM ET Sunday, Nov. 1, 2020 on proposalCENTRAL. Our research grant program offers $100,000 grants for two years ($50,000 per year).
Please read the below before accessing the application portal and template on proposalCENTRAL.
Who Can Apply:
- Investigators who have a doctoral-level degree and a full-time faculty position or equivalent at a college, university, medical school, or eligible not-for-profit research organization globally.
- Junior investigators with an interest in a carrier focus in mesothelioma are strongly encouraged to apply to this RFA. As part of their application, they should identify an established mesothelioma researcher as their mentor and provide a career development and mentorship plan in the context of their application.
Additional information to be included in the LOI:
- All applications need to focus on pleural and/or peritoneal mesothelioma and should address at least one of the 2020 Areas of Interest (listed below).
- All projects must be feasible within the timeline and budgetary constraints of the current RFA.
- All other funding, overlapping and/or supplemental funding, for the proposed project should be disclosed as part of the application.
2020 Areas of Interest:
- Novel therapies for mesothelioma for both pleural and peritoneal (focus on – targeted therapies, combination immunotherapy, cellular therapy, virotherapy)
- Novel strategies for screening and early detection
- Immune mediated complications of immunotherapy in mesothelioma (monitoring, early detection and management)
- Improving personalization of therapies (gender and racial differences, targeted therapies and predictive biomarkers)
- Mechanisms of treatment resistance/failure
- Improvement Quality of life in mesothelioma patients (treatment related /toxicities and survivorship issues)
- Improvement of Mental Health in mesothelioma patients
- Mesothelioma Biology and Etiology (disease-defining molecular pathways, cellular biology, and/or tumor microenvironment)
For questions, please contact Jordan Fingerhut, Patient and Grants Program Senior Associate, at [email protected] or 703-879-3824.
